CINECA IRIS Institutional Research Information System

CANOSA, Antonio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.454
EU - Europa 3.332
AS - Asia 1.356
SA - Sud America 54
OC - Oceania 36
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 7
Totale 9.254
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.371
IT - Italia 1.246
CN - Cina 695
IE - Irlanda 456
SE - Svezia 337
AT - Austria 247
KR - Corea 244
FR - Francia 236
DE - Germania 168
GB - Regno Unito 123
FI - Finlandia 110
IN - India 93
VN - Vietnam 92
JP - Giappone 89
UA - Ucraina 77
CA - Canada 75
PL - Polonia 55
ES - Italia 51
BE - Belgio 50
NL - Olanda 46
SG - Singapore 36
BR - Brasile 32
AU - Australia 29
UZ - Uzbekistan 28
GR - Grecia 21
TR - Turchia 21
HK - Hong Kong 17
RU - Federazione Russa 14
CH - Svizzera 12
DK - Danimarca 12
PT - Portogallo 11
RO - Romania 11
CZ - Repubblica Ceca 10
CO - Colombia 9
TW - Taiwan 9
IL - Israele 8
BG - Bulgaria 7
CL - Cile 7
EU - Europa 7
MX - Messico 7
NZ - Nuova Zelanda 7
HR - Croazia 6
BY - Bielorussia 5
HU - Ungheria 5
PH - Filippine 5
BA - Bosnia-Erzegovina 4
EG - Egitto 4
ID - Indonesia 4
NO - Norvegia 4
SN - Senegal 4
AR - Argentina 3
IR - Iran 3
ZA - Sudafrica 3
IQ - Iraq 2
MK - Macedonia 2
MT - Malta 2
MU - Mauritius 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CR - Costa Rica 1
CY - Cipro 1
EC - Ecuador 1
IM - Isola di Man 1
KZ - Kazakistan 1
LB - Libano 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
RS - Serbia 1
SA - Arabia Saudita 1
Totale 9.254
Salva come PNG Salva come JPEG
Città #
Chandler 824
Dublin 444
Beijing 354
Torino 293
Vienna 242
Ashburn 240
Fairfield 232
Houston 160
Nyköping 148
Wilmington 145
Ann Arbor 136
Princeton 118
Medford 116
Seattle 116
Villeurbanne 114
Turin 111
Jacksonville 110
Woodbridge 106
Cambridge 87
Redwood City 83
Milan 77
Fremont 58
Dearborn 55
Dong Ket 54
Warsaw 51
Boston 46
Pisa 45
Hangzhou 35
Chengdu 33
Rome 33
Brussels 30
Toronto 29
Paris 26
New York 25
Shanghai 24
Boardman 22
Tokyo 19
Washington 19
Nanjing 18
Seoul 18
Cervignano Del Friuli 17
San Diego 17
Falls Church 16
Hebei 16
Ottawa 16
Chicago 15
Norwalk 15
Bologna 13
Guangzhou 13
London 13
Padova 13
Moncalieri 12
Singapore 12
Amsterdam 11
Hefei 11
Mountain View 10
Palermo 10
Pune 10
San Mauro Torinese 10
Duncan 9
Genova 9
Guiyang 9
Helsinki 9
Kunming 9
Stockholm 9
Sydney 9
Buffalo 8
Cagliari 8
Dronten 8
Florence 8
Nanchang 8
New Delhi 8
Silver Spring 8
Bengaluru 7
Bethesda 7
Grugliasco 7
Siena 7
Xian 7
Zhengzhou 7
Alpignano 6
Atlanta 6
Bari 6
Cascina 6
Chennai 6
Detroit 6
Dundee 6
Fuzhou 6
Goiânia 6
Hong Kong 6
Istanbul 6
Lappeenranta 6
Las Vegas 6
Limoges 6
Madrid 6
Munich 6
Oxford 6
Phoenix 6
Portadown 6
Prague 6
Salerno 6
Totale 5.433
Salva come PNG Salva come JPEG
Nome #
Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine: a population-based study 570
The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients. 373
Acoustic reflex patterns in amyotrophic lateral sclerosis 279
ATXN2 is a modifier of phenotype in ALS patients of Sardinian ancestry 223
Validation of the revised classification of cognitive and behavioural impairment in ALS 219
Acute, Hemorrhagic, Necrotizing Pancreatitis Associated With Riluzole Treatment in a Patient With Amyotrophic Lateral Sclerosis 203
The role of arterial blood gas analysis (ABG) in amyotrophic lateral sclerosis respiratory monitoring 198
ATXN2 polyQ intermediate repeats are a modifier of ALS survival. 184
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. 180
18 F-FDG-PET correlates of cognitive impairment in ALS 172
Cognitive correlates in amyotrophic lateral sclerosis: a population-based study in Italy. 170
CHCH10 mutations in an Italian cohort of familial and sporadic amyotrophic lateral sclerosis patients 170
Amyotrophic lateral sclerosis onset after prolonged treatment with a VEGF receptors inhibitor. 165
Validation of the Italian version of self-administered ALSFRS-R scale 161
Secular trends of amyotrophic lateral sclerosis: The Piemonte and Valle d’Aosta register 148
A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis 147
The multistep hypothesis of ALS revisited: The role of genetic mutations 134
Does Recognition of Facial Expression of Primary and Social Emotions in ASL Patients Interfere with Social Competence? 133
A novel p.Ser108LeufsTer15 SOD1 mutation leading to the formation of a premature stop codon in an apparently sporadic ALS patient: insights into the underlying pathomechanisms 129
Spatial epidemiology of Amyotrophic Lateral Sclerosis in Piedmont and Aosta Valley, Italy: a population-based cluster analysis 128
Correlation between Apolipoprotein E genotype and brain metabolism in amyotrophic lateral sclerosis 122
Can eye-tracking system communication improve quality of life and mood in ALS patients with locked-in syndrome 121
Influence of cigarette smoking on ALS outcome: A population-based study 116
Persistent idiopathic hypoglossal nerve palsy: A motor neuron disease-mimic syndrome? 114
Expression of NOX2 protein in neutrophils of patients with ALS 107
Multicenter validation of [18F]-FDG PET and support-vector machine discriminant analysis in automatically classifying patients with amyotrophic lateral sclerosis versus controls 103
Genetic counselling in ALS: facts, uncertainties and clinical suggestions 102
Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study 97
Cognitive impairment across ALS clinical stages in a population-based cohort 93
Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis 90
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution 89
Lithium carbonate does not prevent ALS: a case-report of four patients on long-term therapy for the treatment of bipolar disorder 87
NADPH oxidase (NOX2) activity is a modifier of survival in ALS 87
Does Recognition of Facial Expression of Primary and Social Emotions in ALS Patients Interfere with Social Competence? 86
ALS clinical trials: Do enrolled patients accurately represent the ALS population? 86
NADPH oxidase (NOX2) activity is a modifier of survival in ALS. 83
A novel p.E121G heterozygous missense mutation of SOD1 in an apparently sporadic ALS case with a 14-year course. 83
Segni e sintomi inusuali o rari in Neurologia 83
Early weight loss in amyotrophic lateral sclerosis: Outcome relevance and clinical correlates in a population-based cohort 81
A familial ALS case carrying a novel p.G147C SOD1 heterozygous missense mutation with non-executive cognitive impairment. 80
ALS Clinical Trials: Do the Enrolled Patients Represent the ALS Population? 79
Common polymorphisms of chemokine (C-X3-C motif) receptor 1 gene modify amyotrophic lateral sclerosis outcome: A population-based study 78
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis 76
Regional spreading of symptoms at diagnosis as a prognostic marker in amyotrophic lateral sclerosis: A population-based study 76
DETECTING COGNITIVE CHANGES IN ALS: A POPULATION-BASED STUDY 75
Prognostic influence of pre-morbid smoking habits, diabetes, arterial hypertension and vascular risk profile on phenotype and outcome of ALS patients: a population-based study. 75
Amyotrophic lateral sclerosis/frontotemporal dementia with predominant manifestations of obsessive-compulsive disorder associated to GGGGCC expansion of the c9orf72 gene 72
An ALS-FTD Patient Carrying a Double Pathogenetic Mutation of C9ORF72 and TARDBP: Case Report 70
Frontotemporal dementia in three cases of familial amyotrophic lateral sclerosis with TARDBP A382T mutation 70
Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study 66
An ALS case with a novel D90N-SOD1 heterozygous missense mutation 65
ALS phenotype is influenced by age, sex, and genetics: A population-based study 63
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 63
Lifetime sport practice and brain metabolism in Amyotrophic Lateral Sclerosis 63
A de novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. 62
TBK1 is associated with ALS and ALS-FTD in Sardinian patients 61
Amyotrophic lateral sclerosis with SOD1 mutations shows distinct brain metabolic changes 61
Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study 60
Amyotrophic lateral sclerosis caregiver burden and patients’ quality of life during COVID-19 pandemic 60
ALS/FTD phenotype in two Sardinian families carrying both C9ORF72 and TARDBP mutations 59
Genetic architecture of ALS in Sardinia. 58
Monomelic amyotrophy is not always benign: A case report 57
What’s ALS? ALS clinical phenotypes in an Italian register 57
Pain in amyotrophic lateral sclerosis: a population-based controlled study 57
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis 57
Differential neuropsychological profile of ALS patients with and without C9orf72 mutation 57
Italian adaptation of the Beaumont Behavioral Inventory (BBI): psychometric properties and clinical usability 56
Pain in ALS: a case-control study 53
Association of Variants in the SPTLC1 Gene with Juvenile Amyotrophic Lateral Sclerosis 53
Telemedicine for patients with amyotrophic lateral sclerosis during COVID-19 pandemic: an Italian ALS referral center experience 53
UNC13A influences survival in Italian amyotrophic lateral sclerosis patients: a population-based study 52
The role of APOE in the occurrence of frontotemporal dementia in amyotrophic lateral sclerosis 52
Brain metabolic changes across King’s stages in amyotrophic lateral sclerosis: a 18F-2-fluoro-2-deoxy-d-glucose-positron emission tomography study 52
Religiousness is positively associated with quality of life of ALS caregivers 50
GBA variants influence cognitive status in amyotrophic lateral sclerosis 50
Comorbidity of Cervical Spondylogenic Myelopathy and Amyotrophic Lateral Sclerosis: When Electromyography Makes the Difference in Diagnosis 49
Do ecological factors influence the clinical presentation of amyotrophic lateral sclerosis? 49
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosis 48
Decline of cognitive and behavioral functions in amyotrophic lateral sclerosis: a longitudinal study 48
A familial amyotrophic lateral sclerosis pedigree discordant for a novel p.Glu46Asp heterozygous OPTN variant and the p.Ala5Val heterozygous SOD1 missense mutation 48
Metabolic brain changes across different levels of cognitive impairment in ALS: a 18F-FDG-PET study 48
Effects of intracellular calcium accumulation on proteins encoded by the major genes underlying amyotrophic lateral sclerosis 48
Clinical phenotypes in amyotrophic lateral sclerosis: a population-based study in Italy 47
A novel splice site FUS mutation in a familial ALS case: effects on protein expression 46
Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud 44
Developments in the assessment of non-motor disease progression in amyotrophic lateral sclerosis 43
TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients 42
Tailoring patients’ enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffs 41
Validation of the Italian version of the Rasch-Built Overall Amyotrophic Lateral Sclerosis Disability Scale (ROADS) administered to patients and their caregivers 40
Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort 38
Neck flexor weakness at diagnosis predicts respiratory impairment in amyotrophic lateral sclerosis 38
The characteristics of cognitive impairment in als patients depend on the lateralization of motor damage 37
The heterozygous deletion c.1509_1510delAG in exon 14 of FUS causes an aggressive childhood-onset ALS with cognitive impairment 34
Prospective epidemiological registers: a valuable tool for uncovering ALS pathogenesis 33
Plateaus in amyotrophic lateral sclerosis progression: results from a population-based cohort 33
Prognostic role of slow vital capacity in amyotrophic lateral sclerosis 33
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology 33
Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture 32
What is amyotrophic lateral sclerosis prevalence? 30
Genome-wide study of DNA methylation shows alterations in metabolic, inflammatory, and cholesterol pathways in ALS 30
Totale 9.176
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.064
article - articoli 0
book - libri 0
conference - conferenze 3.530
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.594
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019283 0 0 0 0 0 0 0 0 0 67 131 85
2019/2020944 40 35 37 95 40 110 122 96 130 128 55 56
2020/20211.224 79 88 82 59 114 97 88 104 177 111 57 168
2021/20221.602 65 31 80 133 119 75 89 74 83 172 396 285
2022/20232.518 276 242 66 228 224 585 165 162 248 97 133 92
2023/20241.227 188 235 115 114 98 145 119 104 27 82 0 0
Totale 9.583